HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Personalized Immunotherapy

Personalized Immunotherapy

Personalized immunotherapy is revolutionizing cancer treatment by tailoring therapies to individual patients' immune systems and tumor characteristics. This approach harnesses the body's immune response to specifically target and destroy cancer cells while minimizing damage to healthy tissue. By analyzing the genetic makeup of tumors and the immune profiles of patients, researchers can develop personalized treatments such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. These therapies offer the potential for more effective and durable responses compared to traditional treatments like chemotherapy and radiation. With ongoing advancements in technology and understanding of the immune system, personalized immunotherapy holds promise for improving outcomes and quality of life for cancer patients in the future.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp